Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Fast magnetic resonance spectroscopic imaging techniques in human brain- applications in multiple sclerosis.

Al-Iedani O, Lechner-Scott J, Ribbons K, Ramadan S.

J Biomed Sci. 2017 Feb 28;24(1):17. doi: 10.1186/s12929-017-0323-2. Review.

2.

Simulating the Effect of Spectroscopic MRI as a Metric for Radiation Therapy Planning in Patients with Glioblastoma.

Cordova JS, Kandula S, Gurbani S, Zhong J, Tejani M, Kayode O, Patel K, Prabhu R, Schreibmann E, Crocker I, Holder CA, Shim H, Shu HK.

Tomography. 2016 Dec;2(4):366-373. doi: 10.18383/j.tom.2016.00187.

3.

A systematic pipeline for the objective comparison of whole-brain spectroscopic MRI with histology in biopsy specimens from grade III glioma.

Cordova JS, Gurbani SS, Olson JJ, Liang Z, Cooper LA, Shu HG, Schreibmann E, Neill SG, Hadjipanayis CG, Holder CA, Shim H.

Tomography. 2016 Jun;2(2):106-116.

4.

Regional distributions of brain glutamate and glutamine in normal subjects.

Goryawala MZ, Sheriff S, Maudsley AA.

NMR Biomed. 2016 Aug;29(8):1108-16. doi: 10.1002/nbm.3575.

PMID:
27351339
5.

Physiological neuronal decline in healthy aging human brain - An in vivo study with MRI and short echo-time whole-brain (1)H MR spectroscopic imaging.

Ding XQ, Maudsley AA, Sabati M, Sheriff S, Schmitz B, Schütze M, Bronzlik P, Kahl KG, Lanfermann H.

Neuroimage. 2016 Aug 15;137:45-51. doi: 10.1016/j.neuroimage.2016.05.014.

PMID:
27164326
6.

Whole-brain spectroscopic MRI biomarkers identify infiltrating margins in glioblastoma patients.

Cordova JS, Shu HK, Liang Z, Gurbani SS, Cooper LA, Holder CA, Olson JJ, Kairdolf B, Schreibmann E, Neill SG, Hadjipanayis CG, Shim H.

Neuro Oncol. 2016 Aug;18(8):1180-9. doi: 10.1093/neuonc/now036.

PMID:
26984746
7.

Metabolic voxel-based analysis of the complete human brain using fast 3D-MRSI: Proof of concept in multiple sclerosis.

Donadieu M, Le Fur Y, Lecocq A, Maudsley AA, Gherib S, Soulier E, Confort-Gouny S, Pariollaud F, Ranjeva MP, Pelletier J, Guye M, Zaaraoui W, Audoin B, Ranjeva JP.

J Magn Reson Imaging. 2016 Aug;44(2):411-9. doi: 10.1002/jmri.25139.

PMID:
26756662
8.

Subacute Pain after Traumatic Brain Injury Is Associated with Lower Insular N-Acetylaspartate Concentrations.

Widerström-Noga E, Govind V, Adcock JP, Levin BE, Maudsley AA.

J Neurotrauma. 2016 Jul 15;33(14):1380-9. doi: 10.1089/neu.2015.4098.

PMID:
26486760
9.

Phased-array combination for MR spectroscopic imaging using a water reference.

Abdoli A, Maudsley AA.

Magn Reson Med. 2016 Sep;76(3):733-41. doi: 10.1002/mrm.25992.

PMID:
26413752
10.

Comparison of inter subject variability and reproducibility of whole brain proton spectroscopy.

Veenith TV, Mada M, Carter E, Grossac J, Newcombe V, Outtrim J, Lupson V, Nallapareddy S, Williams GB, Sheriff S, Menon DK, Maudsley AA, Coles JP.

PLoS One. 2014 Dec 17;9(12):e115304. doi: 10.1371/journal.pone.0115304.

11.

Whole-brain quantitative mapping of metabolites using short echo three-dimensional proton MRSI.

Lecocq A, Le Fur Y, Maudsley AA, Le Troter A, Sheriff S, Sabati M, Donnadieu M, Confort-Gouny S, Cozzone PJ, Guye M, Ranjeva JP.

J Magn Reson Imaging. 2015 Aug;42(2):280-9. doi: 10.1002/jmri.24809.

12.

Ligand-based molecular MRI: O-17 JJVCPE amyloid imaging in transgenic mice.

Suzuki K, Igarashi H, Huber VJ, Kitaura H, Kwee IL, Nakada T.

J Neuroimaging. 2014 Nov-Dec;24(6):595-8. doi: 10.1111/jon.12091.

13.

Multivendor implementation and comparison of volumetric whole-brain echo-planar MR spectroscopic imaging.

Sabati M, Sheriff S, Gu M, Wei J, Zhu H, Barker PB, Spielman DM, Alger JR, Maudsley AA.

Magn Reson Med. 2015 Nov;74(5):1209-20. doi: 10.1002/mrm.25510.

14.

Distributions of Magnetic Resonance Diffusion and Spectroscopy Measures with Traumatic Brain Injury.

Maudsley AA, Govind V, Levin B, Saigal G, Harris L, Sheriff S.

J Neurotrauma. 2015 Jul 15;32(14):1056-63. doi: 10.1089/neu.2014.3505.

15.

Volumetric spectroscopic imaging of glioblastoma multiforme radiation treatment volumes.

Parra NA, Maudsley AA, Gupta RK, Ishkanian F, Huang K, Walker GR, Padgett K, Roy B, Panoff J, Markoe A, Stoyanova R.

Int J Radiat Oncol Biol Phys. 2014 Oct 1;90(2):376-84. doi: 10.1016/j.ijrobp.2014.03.049.

16.

Use of high-resolution volumetric MR spectroscopic imaging in assessing treatment response of glioblastoma to an HDAC inhibitor.

Shim H, Wei L, Holder CA, Guo Y, Hu XP, Miller AH, Olson JJ.

AJR Am J Roentgenol. 2014 Aug;203(2):W158-65. doi: 10.2214/AJR.14.12518. Review.

17.

Magnetic resonance spectroscopic imaging in the era of pseudoprogression and pseudoresponse in glioblastoma patient management.

Shim H, Holder CA, Olson JJ.

CNS Oncol. 2013 Sep;2(5):393-6. doi: 10.2217/cns.13.39. No abstract available.

19.

Reproducibility and reliability of short-TE whole-brain MR spectroscopic imaging of human brain at 3T.

Ding XQ, Maudsley AA, Sabati M, Sheriff S, Dellani PR, Lanfermann H.

Magn Reson Med. 2015 Mar;73(3):921-8. doi: 10.1002/mrm.25208.

20.

High-resolution echo-planar spectroscopic imaging of the human calf.

Weis J, Bruvold M, Ortiz-Nieto F, Ahlström H.

PLoS One. 2014 Jan 30;9(1):e87533. doi: 10.1371/journal.pone.0087533.

Supplemental Content

Support Center